Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Infliximab as first-line therapy for severe Crohn's disease?

Cohen RD. Infliximab as first-line therapy for severe Crohn's disease? Inflamm Bowel Dis. 2002 Jan; 8(1):58-9; discussion 63-5.

View in: PubMed

collapse authors with profiles